Journal of Tuberculosis and Lung Disease ›› 2025, Vol. 6 ›› Issue (2): 183-190.doi: 10.19983/j.issn.2096-8493.20250021
• Original Articles • Previous Articles Next Articles
Ruan Shujin1, Chen Jingfang1,2(), Wang Xiufen3, Zhang Dandan3, Li Mengjun1, Meng Ting1
Received:
2025-01-17
Online:
2025-04-20
Published:
2025-04-11
Contact:
Chen Jingfang, Email:Supported by:
CLC Number:
Ruan Shujin, Chen Jingfang, Wang Xiufen, Zhang Dandan, Li Mengjun, Meng Ting. Analysis of factors influencing treatment non-adherence in pulmonary tuberculosis patients and construction of a risk prediction model[J]. Journal of Tuberculosis and Lung Disease , 2025, 6(2): 183-190. doi: 10.19983/j.issn.2096-8493.20250021
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.jtbld.cn/EN/10.19983/j.issn.2096-8493.20250021
特征 | 依从组(167例) | 不依从组(40例) | 统计检验值 | P值 | ||||
---|---|---|---|---|---|---|---|---|
年龄( | 45.4±15.86 | 48.63±19.36 | t=3.342 | 0.069 | ||||
性别 | χ2=2.034 | 0.154 | ||||||
男性 | 92(55.09) | 27(67.50) | ||||||
女性 | 75(44.91) | 13(32.50) | ||||||
治疗类型 | χ2=26.031 | 0.001 | ||||||
初治 | 153(91.62) | 24(60.00) | ||||||
复治 | 14(8.38) | 16(40.00) | ||||||
独居 | χ2=0.765 | 0.382 | ||||||
否 | 127(76.05) | 33(82.50) | ||||||
是 | 40(23.95) | 7(17.50) | ||||||
发生药物不良反应 | χ2=3.095 | 0.079 | ||||||
否 | 80(47.90) | 13(32.50) | ||||||
是 | 87(52.10) | 27(67.50) | ||||||
耐药状况 | χ2=1.989 | 0.159 | ||||||
否 | 134(80.24) | 28(70.00) | ||||||
是 | 33(19.76) | 12(30.00) | ||||||
使用服药督导工具 | χ2=0.248 | 0.619 | ||||||
否 | 110(65.87) | 28(70.00) | ||||||
是 | 57(34.13) | 12(30.00) | ||||||
知道漏服药会影响治疗效果 | χ2=9.198 | 0.002 | ||||||
否 | 36(21.56) | 18(45.00) | ||||||
是 | 131(78.44) | 22(55.00) | ||||||
了解药物的不良反应 | χ2=4.552 | 0.033 | ||||||
否 | 69(41.32) | 24(60.00) | ||||||
是 | 98(58.68) | 16(40.00) | ||||||
满意抗结核治疗效果 | χ2=6.302 | 0.012 | ||||||
否 | 35(20.96) | 16(40.00) | ||||||
是 | 132(79.04) | 24(60.00) | ||||||
中药治疗 | χ2=18.877 | <0.001 | ||||||
否 | 163(97.60) | 31(77.50) | ||||||
是 | 4(2.40) | 9(22.50) | ||||||
医务人员每月随访 | χ2=2.043 | 0.153 | ||||||
否 | 40(23.95) | 14(35.00) | ||||||
是 | 127(76.05) | 26(65.00) | ||||||
接受医务人员健康宣教 | χ2=4.079 | 0.043 | ||||||
否 | 7(4.19) | 5(12.50) | ||||||
是 | 160(95.81) | 35(87.50) | ||||||
PHQ-2量表评分(分) | χ2=1.342 | 0.247 | ||||||
<3 | 88(52.69) | 17(42.50) | ||||||
≥3 | 79(47.31) | 23(57.50) | ||||||
ACCI评分(分) | χ2=13.369 | <0.001 | ||||||
≤4 | 140(83.83) | 23(57.50) | ||||||
>4 | 27(16.17) | 17(42.50) | ||||||
社会支持量表评分(分) | χ2=72.547 | <0.001 | ||||||
≤8 | 23(13.77) | 32(80.00) | ||||||
>8 | 144(86.23) | 8(20.00) |
项目 | β值 | s | Wald χ2值 | P值 | OR值 | 95%CI值 |
---|---|---|---|---|---|---|
常量 | 0.983 | 0.990 | 0.986 | 0.321 | 2.672 | - |
社会支持量表评分>8分 | -3.278 | 0.577 | 32.256 | 0.000 | 0.038 | 0.012~0.117 |
ACCI评分>4分 | 1.450 | 0.604 | 5.764 | 0.016 | 4.262 | 1.305~13.917 |
复治 | 2.105 | 0.629 | 11.206 | 0.001 | 8.207 | 2.393~28.146 |
知道漏服药物会影响治疗效果 | -0.577 | 0.617 | 0.875 | 0.350 | 0.562 | 0.168~1.882 |
了解药物的不良反应 | -0.369 | 0.600 | 0.379 | 0.538 | 0.691 | 0.213~2.241 |
满意抗结核治疗效果 | -0.626 | 0.585 | 1.142 | 0.285 | 0.535 | 0.170~1.685 |
中药治疗 | 2.790 | 0.943 | 8.754 | 0.003 | 16.276 | 2.564~103.306 |
接受医务人员健康宣教 | -0.831 | 0.999 | 0.691 | 0.406 | 0.436 | 0.062~3.087 |
[1] | World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization, 2024. |
[2] | Burkhart PV, Sabaté E. Adherence to long-termtherapies:evidence for action. J Nurs Scholarsh, 2003, 35(3):207. |
[3] | Lee C, Ho C, Liao K, et al. The incidence of tuberculosis recurrence: Impacts of treatment duration of and adherence to standard anti-tuberculous therapy. J Infect Public Health, 2023, 16(11):1778-1783. doi:10.1016/j.jiph.2023.09.005. |
[4] | 郑沙沙, 周红燕. 肺结核复诊依从性的影响因素. 国际护理学杂志, 2023, 42(20):3711-3714. doi:10.3760/cma.j.cn221370-20220511-00903. |
[5] | Chauhan A, Parmar M, Dash GC, et al. Health literacy and tuberculosis control: systematic review and meta-analysis. Bull World Health Organ, 2024, 102(6):421-431. doi:10.2471/BLT.23.290396. |
[6] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09. |
[7] | Riley RD, Ensor J, Snell KIE, et al. Calculating the sample size required for developing a clinical prediction model. BMJ, 2020, 368:m441. doi:10.1136/bmj.m441. |
[8] | 席明霞, 屈婧, 肖美慧, 等. 耐药肺结核患者服药依从性影响因素的质性研究. 华西医学, 2021, 36(1):50-54. doi:10.7507/1002-0179.201912038. |
[9] | 丰达星, 张璐, 吕宛玉, 等. 我国耐多药结核患者治疗依从性影响因素meta分析. 实用预防医学, 2019, 26(7):823-826. doi:10.3969/j.issn.1006-3110.2019.07.014. |
[10] |
Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol, 1994, 47(11):1245-1251. doi:10.1016/0895-4356(94)90129-5.
pmid: 7722560 |
[11] | Takada Y, Kawashima H, Ohno E, et al. The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors. J Gastroenterol, 2022, 57(3):199-207. doi:10.1007/s00535-022-01853-z. |
[12] | Kocalevent RD, Berg L, Beutel ME, et al. Social support in the general population: standardization of the Oslo social support scale (OSSS-3). BMC Psychol, 2018, 6(1):31. doi:10.1186/s40359-018-0249-9. |
[13] |
Zhang D, Yuan T, Huang A, et al. Validation of the Chinese version of the Oslo-3 Social Support Scale among nursing students: a study based on Classical Test Theory and Item Response Theory Models. BMC Nurs, 2024, 23(1):360. doi:10.1186/s40359-018-0249-9.
pmid: 38816705 |
[14] |
Pitts BH, Sheeder J, Sigel E, et al. Informing Use of the Patient Health Questionnaire-2 to Detect Moderate or Greater Depression Symptoms in Adolescents and Young Adults in Outpatient Primary Care. J Adolesc Health, 2023, 73(2):331-337. doi:10.1016/j.jadohealth.2023.02.043.
pmid: 37125985 |
[15] | 宋花玲, 贺佳, 黄品贤, 等. ROC曲线下面积估计的参数法与非参数法的应用研究. 第二军医大学学报, 2006, 27(7):726-728. doi:10.16781/j.0258-879x.2006.07.011. |
[16] | 王春雷, 金韬, 赵鹏鹏, 等. 江苏省淮安市耐多药肺结核患者服药依从性及影响因素分析. 中国防痨杂志, 2022, 44(10):1057-1062. doi:10.19982/j.issn.1000-6621.20220214. |
[17] | 余雅, 廖文平, 刘英, 等. 重庆市贫困区(县)肺结核患者的治疗依从性及其影响因素研究. 疾病监测, 2021, 36(11):1159-1167. doi:10.3784/jbjc.202105060233. |
[18] | 张晗, 王丽霞, 魏玉石, 等. 数字化治疗依从性技术在肺结核患者服药管理中的应用效果评价. 中国防痨杂志, 2024, 46(2):158-164. doi:10.19982/j.issn.1000-6621.20230283. |
[19] | 张燕, 王森路, 日孜宛古力·热合曼, 等. 新疆维吾尔自治区和田地区“肺结核主动筛查+全疗程住院治疗”模式对患者发现的效果. 中国防痨杂志, 2024, 46(2):145-150. doi:10.19982/j.issn.1000-6621.20230284. |
[20] |
Ajema D, Shibru T, Endalew T, et al. Level of and associated factors for non-adherence to anti-tuberculosis treatment among tuberculosis patients in Gamo Gofa zone, southern Ethiopia: cross-sectional study. BMC Public Health, 2020, 20(1):1705. doi:10.1186/s12889-020-09827-7.
pmid: 33187496 |
[21] | 孙慧娟, 苏伟, 陈伟. 利福平耐药结核病患者不良治疗结局及其影响因素研究进展. 结核与肺部疾病杂志, 2024, 5(6):573-582. doi:10.19983/j.issn.2096-8493.2024111. |
[22] | 蒋宇, 杨静, 吴茜, 等. 青年初治肺结核患者服药依从性及其影响因素研究. 中国实用护理杂志, 2023, 39(18):1388-1395. doi:10.3760/cma.j.cn211501-20220527-01666. |
[23] | Chen B, Chen X, Ren Y, et al. Treatment cascade for patients with multidrug- or rifampicin-resistant tuberculosis and associated factors with patient attrition in southeastern China: a retrospective cohort study. J Infect Public Health, 2023, 16(7):1073-1080. doi:10.1016/j.jiph.2023.05.012. |
[24] | Wang Y, Jian S, Huang Z, et al. Medication-related burden and its association with medication adherence among elderly tuberculosis patients in Guizhou, China: a cross-sectional study. Front Pharmacol, 2024, 15:1416005. doi:10.3389/fphar.2024.1416005. |
[25] | 吕春容, 唐晨曦. 2011—2017年成都市艾滋病合并结核病病人流行病学调查及治疗依从性分析. 护理研究, 2019, 33(9):1508-1513. doi:10.12102/j.issn.1009-6493.2019.09.011. |
[26] | 骆梦醒, 邹欣, 高雅娴, 等. 结核病合并基础疾病患者的抗结核治疗效果及肺部损伤分析. 上海交通大学学报(医学版), 2023, 43(8):1017-1023. doi:10.3969/j.issn.1674-8115.2023.08.009. |
[27] | 郭强, 李瑞萍, 马玉宝, 等. 2018—2020年甘肃省利福平敏感肺结核患者治疗不良结局的随机效应logistic模型分析. 结核与肺部疾病杂志, 2022, 3(6):455-462. doi:10.19983/j.issn.2096-8493.20220111. |
[28] | 祝云爱, 徐敏, 张丽君. 耐多药结核病患者遵医行为的影响因素分析. 护理实践与研究, 2021, 18(13):1904-1907. doi:10.3969/j.issn.1672-9676.2021.13.003. |
[29] | 谭隽怡, 向明确, 李天驹, 等. 营养因素与结核病患者预后相关研究进展. 中国感染与化疗杂志, 2024, 24(3):366-370. doi:10.16718/j.1009-7708.2024.03.019. |
[30] | Wagnew F, Gray D, Tsheten T, et al. Effectiveness of nutritional support to improve treatment adherence in patients with tuberculosis: a systematic review. Nutr Rev, 2024, 82(9):1216-1225. doi:10.1093/nutrit/nuad120. |
[31] | 王科山. 强化用药管理对中药制剂合理使用的研讨. 结核与肺部疾病杂志, 2024, 5(S1):61-63. doi:10.19983/j.issn.2096-8493.20240337. |
[32] |
Anthoney J, De Wildt G, Meza G, et al. Patients’ perspectives on factors facilitating adherence to tuberculosis treatment in Iquitos, Peru: a qualitative study. BMC Health Serv Res, 2021, 21(1):345. doi:10.1186/s12913-021-06329-z.
pmid: 33853587 |
[33] | 曹鑫宇, 葛如语, 李小麟, 等. 耐多药结核病患者心理应激反应影响因素及社会支持调节效应的分析. 中华现代护理杂志, 2022, 28(21):2866-2872. doi:10.3760/cma.j.cn115682-20210828-03865. |
[34] | 李本春, 王应军, 曹晓玉. 肺结核患者服药依从性预测模型的建立. 现代医学, 2022, 50(5):529-535. doi:10.3969/j.issn.1671-7562.2022.05.001. |
[35] | Wang S. Development of a nomogram for predicting treatment default under facility-based directly observed therapy short-course in a region with a high tuberculosis burden. Ther Adv Infect Dis, 2021, 8:1998268882. doi:10.1177/20499361211034066. |
[36] | 蔡小芳, 高慧, 葛军, 等. 多重耐药性肺结核治疗依从性预测分析. 中华肺部疾病杂志(电子版), 2024, 17(1):51-56. doi:10.3877/cma.j.issn.1674-6902.2024.01.010. |
[1] | Qian Mengni, Lu Nihong, Du Yingrong. Research progress on the risk of type Ⅱ diabetes complicated with severe pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(2): 225-233. |
[2] | Guo Meng, Zhu Yuhui, Fan Yongde, Li Jingwen. Preliminary study on the predicting of the popularity of papers in the core journals of respiratory disease and tuberculosis in China based on neural network [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 79-86. |
[3] | Liu Fang, Ma Jintong, Liu Yongmei, Luo Peipei, Feng Yang, Liu Zhenlong, Wang Yuhong. Analysis of risk factors of chronic obstructive pulmonary disease complicated with pulmonary tuberculosis with tendency score matching method and construction of a prediction model [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 511-516. |
[4] | Sun Huijuan, Su Wei, Chen Wei. Research progress on unfavourable treatment outcomes and risk factors of rifampicin-resistant tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 573-582. |
[5] | Cai Xiaoting, Wu Xiaoying, He Liqian, Jiang Kunhong. A study on the correlation between family doctor contract services and clinical characteristics of pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 333-338. |
[6] | Wei Yunxia, Wang Xin, Long Xuejuan, Shao Lijiao, Yan Lijing, Yu Di, Li Ning. Clinical value of IFIT3 and PCT in prognosis evaluation of elderly patients with severe tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 143-147. |
[7] | Fu Yiting, Liu Lei, Zhao Qian, Meng Jixian, Zhen Ziyi, Wang Yang, Li Rongmei. Analysis of risk factors and construction of risk prediction model for anemia in patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 20-27. |
[8] | Xue Jianhang, Cao hong, Li Lu, Liu Xunrui, Ma Guilin, Zheng Rongrong, Ke Ran. Analysis of treatment outcome and influencing factors of 308 patients with multidrug-resistant pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 44-50. |
[9] | You Guoqing, Liu Wenguo, Feng Xin, Yu Min, Shi Lin, Hu Yan. Analysis of fluoroquinolones resistance in multidrug-resistant tuberculosis patients in Chongqing from 2020 to 2022 [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 475-479. |
[10] | Ma Jianjun, Zhang Tiejuan, Zhao Qinglong, Yu Shihui, Mei Yang. Random forest algorithm-based study of risk factors for tuberculosis incidence in an elderly mobile population [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(5): 364-369. |
[11] | Li Jing, He Jinge, Li Ting, Li Yunkui, Gao Wenfeng. Analysis of feasibility and effectiveness of the implementation of strengthened tuberculosis management model in Liangshan Yi Autonomous Prefecture, Sichuan Province [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(6): 449-454. |
[12] | Xin Chaojun, Cao lijing, Lyu Lige. Analysis of risk factors of recurrent respiratory tract infections in children [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(4): 300-304. |
[13] | WANG Lin, SHEN Xue-qing, YAN Ting-ting. Analysis of prognostic factors of pulmonary infection after 2 weeks of treatment in hospitalized elderly stroke patients [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(3): 181-186. |
[14] | XIAN Shao-jing, CHEN Yan, MA Yi-ming, LUO Li-juan, LONG Ying-jiao. Analysis of the characteristics of the composition of respiratory pathogens and its influencing factors in patients hospitalized with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(3): 209-215. |
[15] | LI He-rui, LUO Li-juan, ZENG Zi-hang, CHEN Yan. Advances in candidiasis in chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(1): 44-49. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||